Correlation Between Recursion Pharmaceuticals and 737446AQ7

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and 737446AQ7 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and 737446AQ7 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and Post Holdings 4625, you can compare the effects of market volatilities on Recursion Pharmaceuticals and 737446AQ7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of 737446AQ7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and 737446AQ7.

Diversification Opportunities for Recursion Pharmaceuticals and 737446AQ7

-0.52

Correlation Coefficient

Recursion Pharmaceuticals  737446AQ7

Excellent diversification

The 3 months correlation between Recursion and 737446AQ7 is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Post Holdings 4625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Post Holdings 4625 and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with 737446AQ7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Post Holdings 4625 has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and 737446AQ7 go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and 737446AQ7

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 8.57 times more return on investment than 737446AQ7. However, Recursion Pharmaceuticals is 8.57 times more volatile than Post Holdings 4625. It trades about 0.03 of its potential returns per unit of risk. Post Holdings 4625 is currently generating about -0.19 per unit of risk. If you would invest  691.00  in Recursion Pharmaceuticals on September 18, 2024 and sell it today you would earn a total of  19.00  from holding Recursion Pharmaceuticals or generate 2.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  Post Holdings 4625

Recursion Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Post Holdings 4625

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Post Holdings 4625 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for Post Holdings 4625 investors.

Pair Trading with Recursion Pharmaceuticals and 737446AQ7

The main advantage of trading using opposite Recursion Pharmaceuticals and 737446AQ7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, 737446AQ7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 737446AQ7 will offset losses from the drop in 737446AQ7's long position.

The idea behind Recursion Pharmaceuticals and Post Holdings 4625 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.